Treat novelty as a development program with explicit identity, feasibility, supply, and commercialization gates.
The source context
FDA describes a notification process for new dietary ingredients, subject to applicable requirements and exceptions. A novel ingredient needs a regulatory assessment specific to its identity and intended use. Source ↗
PCG perspective · The following is our proposed development framework, not a finding of the cited source.
Define the material precisely
Write down what the proposed ingredient is, how it is produced, and which characteristics matter to the product. Similar names can hide meaningful differences in composition or processing. The commercial brief should connect that identity to a consumer need. Novelty without a clear role can generate a long development program with no convincing reason for a customer to choose the result.
Run feasibility work in parallel
Technical characterization, sourcing, regulatory assessment, and commercial evaluation should inform one another. Do not wait until a marketing concept is fixed before asking whether the material can be supplied consistently or used as intended. Maintain a list of decision-critical uncertainties and an owner for each. This makes it easier to see whether a project is progressing or simply accumulating activity.
Agree on ownership and access
Discuss the rights to specifications, data, improvements, and supply arrangements before substantial work is commissioned. Identify what happens if the project stops or the commercial relationship changes. These matters need appropriate professional review, but they also belong in the development conversation because they affect whether the brand can sustain the proposed differentiation over time.
Use gates tied to evidence
A useful sequence is identity and feasibility, prototype fit, supply readiness, and commercialization readiness. At each gate, state what evidence is required and what remains unresolved. Keep a viable alternative available where possible. A disciplined process can preserve ambition while preventing a promising material from carrying the entire launch schedule before the basic questions have been answered.
Source & scope
FDA: New Dietary Ingredient Notification Process ↗US regulatory resource; checked September 21, 2026. Sources checked September 21, 2026. Product-specific scientific and regulatory conclusions require appropriate specialist review.
How we prepare and update insightsTurn the question into a development brief.
Explore formulation, sourcing, research, or portfolio decisions with Product Concept Group.
Discuss this opportunity ↗